Policy / Pricing UK commits to pharma IP protection in Swiss trade deal Pharmaceutical TechnologyThe pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreementRead full story pharminent July 16, 2026 (Last updated: July 20, 2026) Pharmaceutical Technology The pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreement Read full story Post navigation Previous: FDA Approves At-Home Leqembi for Early Alzheimer’s DiseaseNext: Merck Wins First FDA Approval of an Oral PCSK9 Inhibitor with Cholesterol Pill Lipfendra Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026